PulseMedica has developed a proprietary real-time 3D imaging and laser targeting system for precise retinal surgery. Our patented next generation ultrafast femtosecond laser ophthalmic treatment will enable treatment for retinal diseases such as age-related macular degeneration (AMD) and glaucoma, for which there is currently no cure.
PulseMedica is a company based out of Edmonton, AB, Canada.
Company’s Keywords:
medical device, femtosecond laser, ophthalmology
<23
<
<2018